Scynexis, Inc. (SCYX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Scynexis, Inc. (SCYX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Scynexis, Inc. (SCYX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Scynexis, Inc. (SCYX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
31 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Scynexis, Inc. (Scynexis) discovers, develops and commercializes novel anti-infective for various therapeutic needs. The companys pipeline products comprise SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis C (HCV); SCYX-7158, is used for sleeping sickness; SCY-641, is for human health. Its SCY-078 is a chemical class of glucan synthase inhibitors that blocks target in infectious fungi by interfering with the assembly of the fungal cell wall and prevents the growth of fungal species. Scynexis provides its drug pipeline solutions to pharmaceutical, healthcare and life sciences companies.

Scynexis, Inc. (SCYX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on ma

  
Source:
Document ID
GDPH122661D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Scynexis, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Scynexis, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Scynexis, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Scynexis, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Scynexis, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Scynexis, Inc., Pharmaceuticals &Healthcare, Deal Details1018
  Venture Financing101
    Scynexis Raises Additional US$6 Million In Venture Financing101
  Partnerships111
    Scynexis Enters Into Co-Marketing Agreement With R-Pharm For SCY-078111
    Morria BioPharma Enters Into Co-Development Agreement With SCYNEXIS For MRX-4121
    SCYNEXIS Enters Into An Agreement With TB Alliance131
  Licensing Agreements141
    Scynexis Enters into Licensing Agreement with Waterstone Pharma for SCY-635142
    Merck Terminates Licensing Agreement With Scynexis For MK-3118162
  Equity Offering181
    Scynexis Prices Public Offering of Shares and Warrants for USD22.5 Million182
    Scynexis Raises USD41 Million in Public Offering of Shares202
    Scynexis Raises USD62 Million in IPO222
  Asset Transactions241
    Cypralis to Acquire Cyclophilin Inhibitor Assets from Scynexis241
    Avista Pharma Acquires Contract Services Business from Scynexis252
    Accelrys Acquires Hit Explorer Operating System From Scynexis271
Scynexis, Inc. - Key Competitors281
Key Employees291
Locations And Subsidiaries301
  Head Office301
Appendix311
  Methodology311
  About GlobalData311
  Contact Us311
  Disclaimer311

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Scynexis, Inc. (SCYX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Scynexis-Inc-SCYX-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-3071>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Scynexis, Inc. (SCYX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Scynexis-Inc-SCYX-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-3071>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research